Glenmark Pharma gets USFDA nod for antiplatelet drug

Glenmark Pharma gets USFDA nod for antiplatelet drug Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food Drug Administration (USFDA) for Aspirin and extended-release Dipyridamole capsules in the strength of 25 mg/200 mg, the company said in a BSE filing.
This entry was posted in Global India, Market News, News. Bookmark the permalink.

Comments are closed.